focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.55
Bid: 145.05
Ask: 145.10
Change: -1.85 (-1.26%)
Spread: 0.05 (0.034%)
Open: 146.45
High: 147.85
Low: 142.45
Prev. Close: 146.40
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

13 Jan 2022 10:19

RNS Number : 3584Y
Centrica PLC
13 January 2022
 

 

Centrica plc

(the "Company")

 

Results of General Meeting regarding proposed sale of Spirit Energy's Norwegian business and interests in the Statfjord field and amended joint venture arrangements

Centrica plc held a general meeting ("General Meeting") in relation to the proposed sale of Spirit Energy's Norwegian business and interests in the Statfjord field and amended joint venture arrangements (the "Transaction") at Heathrow/Windsor Marriott Hotel, Ditton Road, Langley, Slough SL3 8PT at 9.00 a.m. on 13 January 2022. The resolution proposed at the General Meeting was decided on a poll and was passed. The results are set out below.

As previously announced, the completion of the Transaction remains subject to the satisfaction or waiver of the conditions summarised in the circular published in connection with the Transaction ("Circular"). The Transaction is expected to complete in the second quarter of 2022. 

The results are set out below:

Resolution

For*

%

Against

%

Total votes cast

% Issued Capital**

Withheld***

1.

To approve the Transaction as described in the Circular and to authorise the directors to give effect to the Transaction

3,840,949,656

99.94

2,317,646

0.06

3,843,267,302

65.35%

1,905,737

 

Notes to the disclosure:

*

Includes discretionary votes received

**

The total number of ordinary shares of 614/81 pence in issue, excluding shares held in treasury was 5,881,495,064 Shareholders are entitled to one vote per share.

***

A 'Vote withheld' is not a vote in law and is not counted towards the proportion of votes 'For' or 'Against' a resolution.

 

Copies of our announcements are available on our website: centrica.com/investors/rns-tools/rns-announcements

In accordance with Listing Rule 9.6.2, a copy of the resolution passed as special business has been submitted to the UK Listing Authority and will shortly be available for inspection at the National Storage Mechanism document viewing facility at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Enquiries:

Centrica

Investor and Analysts: Media Relations:

T: 01753 494900 T: 01784 84300

E: ir@centrica.com E: media@centrica.com

Goldman Sachs International (Sole Sponsor and Lead Financial Adviser)

Karen Cook, Mark Sorrell, Brian O'Keeffe, Bertie Whitehead+44 (0) 20 7774 1000

Robey Warshaw LLP (Financial Adviser)

Simon Robey+44 (0) 20 7317 3900

Cautionary statement

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

Important information relating to financial advisers

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as sponsor and lead financial adviser to Centrica and for no one else in connection with the Transaction and will not be responsible to anyone other than Centrica for providing the protections afforded to clients of Goldman Sachs or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Robey Warshaw LLP ("Robey Warshaw"), which is authorised and regulated in the U.K. by the FCA, is acting as financial adviser exclusively for Centrica and no one else in connection with the Transaction and will not be responsible to anyone other than Centrica for providing the protections afforded to clients of Robey Warshaw, nor for providing advice in relation to the Transaction or any other matters or arrangements referred to in this announcement.

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMMZGMMGFVGZZM
Date   Source Headline
26th Sep 20236:20 pmRNSTransaction in Own Shares
25th Sep 20236:15 pmRNSTransaction in Own Shares
25th Sep 20236:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20236:30 pmRNSTransaction in Own Shares
21st Sep 20236:25 pmRNSTransaction in Own Shares
20th Sep 20236:20 pmRNSTransaction in Own Shares
19th Sep 20236:20 pmRNSTransaction in Own Shares
18th Sep 20236:15 pmRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20236:15 pmRNSTransaction in Own Shares
13th Sep 20236:15 pmRNSTransaction in Own Shares
12th Sep 20236:20 pmRNSTransaction in Own Shares
12th Sep 20235:10 pmRNSDirector/PDMR Shareholding
11th Sep 20236:15 pmRNSTransaction in Own Shares
8th Sep 20236:25 pmRNSTransaction in Own Shares
7th Sep 20236:30 pmRNSTransaction in Own Shares
5th Sep 20236:00 pmRNSTransaction in Own Shares
4th Sep 20236:15 pmRNSTransaction in Own Shares
1st Sep 20236:25 pmRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
31st Aug 20236:10 pmRNSTransaction in Own Shares
30th Aug 20236:15 pmRNSTransaction in Own Shares
29th Aug 20236:25 pmRNSTransaction in Own Shares
25th Aug 20236:30 pmRNSTransaction in Own Shares
25th Aug 20231:00 pmRNSDirector/PDMR Shareholding
24th Aug 20236:00 pmRNSTransaction in Own Shares
23rd Aug 20236:20 pmRNSTransaction in Own Shares
22nd Aug 20236:20 pmRNSTransaction in Own Shares
21st Aug 20236:25 pmRNSTransaction in Own Shares
18th Aug 20236:31 pmRNSTransaction in Own Shares
17th Aug 20236:25 pmRNSTransaction in Own Shares
16th Aug 20236:15 pmRNSTransaction in Own Shares
15th Aug 20236:25 pmRNSTransaction in Own Shares
14th Aug 20236:25 pmRNSTransaction in Own Shares
11th Aug 20236:30 pmRNSTransaction in Own Shares
11th Aug 20232:00 pmRNSDirectorate Change
11th Aug 20231:00 pmRNSDirector/PDMR Shareholding
10th Aug 20236:30 pmRNSTransaction in Own Shares
9th Aug 20236:00 pmRNSTransaction in Own Shares
8th Aug 20236:25 pmRNSTransaction in Own Shares
7th Aug 20236:15 pmRNSTransaction in Own Shares
4th Aug 20236:25 pmRNSTransaction in Own Shares
1st Aug 20235:15 pmRNSTotal Voting Rights
28th Jul 20231:00 pmRNSCorrection – interim dividend payment disclosure
27th Jul 20237:00 amRNSHalf-year Report
26th Jul 20236:20 pmRNSTransaction in Own Shares
25th Jul 20236:15 pmRNSTransaction in Own Shares
25th Jul 202311:15 amRNSDirector/PDMR Shareholding
24th Jul 20236:15 pmRNSTransaction in Own Shares
24th Jul 20235:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.